Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
GLP-1 agonists promote the release of insulin in response to hyperglycaemia, inhibit the secretion of glucagon, slow gastric emptying, and augment satiety by directly affecting the central nervous system 1
Its ability to influence insulin and glucagon secretion also contributes to better blood sugar control, which is essential for effective weight management
Comparing New findings with Mounjaro At higher doses (7.2 mg), Wegovy has demonstrated weight loss outcomes that closely mirror those achieved with Mounjaro
The company's stock was down about 15% in mid-day trading on Tuesday following the unexpected Q1 loss
US$ 23.17
US$ 20.90
US$ 21.70
